101 related articles for article (PubMed ID: 12646288)
21. Differential inhibition of foot tapping and chromodacryorrhoea in gerbils by CNS penetrant and non-penetrant tachykinin NK1 receptor antagonists.
Rupniak NM; Williams AR
Eur J Pharmacol; 1994 Nov; 265(3):179-83. PubMed ID: 7533096
[TBL] [Abstract][Full Text] [Related]
22. Immediate-early gene expression in the central nucleus of the amygdala is not specific for anxiolytic or anxiogenic drugs.
Thompson BL; Rosen JB
Neuropharmacology; 2006 Jan; 50(1):57-68. PubMed ID: 16185722
[TBL] [Abstract][Full Text] [Related]
23. Chromodacryorrhea and repetitive hind paw tapping: models of peripheral and central tachykinin NK1 receptor activation in gerbils.
Bristow LJ; Young L
Eur J Pharmacol; 1994 Mar; 253(3):245-52. PubMed ID: 7515350
[TBL] [Abstract][Full Text] [Related]
24. In vitro and in vivo predictors of the anti-emetic activity of tachykinin NK1 receptor antagonists.
Rupniak NM; Tattersall FD; Williams AR; Rycroft W; Carlson EJ; Cascieri MA; Sadowski S; Ber E; Hale JJ; Mills SG; MacCoss M; Seward E; Huscroft I; Owen S; Swain CJ; Hill RG; Hargreaves RJ
Eur J Pharmacol; 1997 May; 326(2-3):201-9. PubMed ID: 9196273
[TBL] [Abstract][Full Text] [Related]
25. Yokukansan, a traditional Japanese herbal medicine, enhances the anxiolytic effect of fluvoxamine and reduces cortical 5-HT
Ohno R; Miyagishi H; Tsuji M; Saito A; Miyagawa K; Kurokawa K; Takeda H
J Ethnopharmacol; 2018 Apr; 216():89-96. PubMed ID: 29382554
[TBL] [Abstract][Full Text] [Related]
26. Differential expression of EGR-1 mRNA in the amygdala following diazepam in contextual fear conditioning.
Malkani S; Rosen JB
Brain Res; 2000 Mar; 860(1-2):53-63. PubMed ID: 10727623
[TBL] [Abstract][Full Text] [Related]
27. Effects of central administration of tachykinin receptor agonists and antagonists on plus-maze behavior in mice.
Teixeira RM; Santos AR; Ribeiro SJ; Calixto JB; Rae GA; De Lima TC
Eur J Pharmacol; 1996 Sep; 311(1):7-14. PubMed ID: 8884230
[TBL] [Abstract][Full Text] [Related]
28. Chronic substance P (NK1) receptor antagonist and conventional antidepressant treatment increases burst firing of monoamine neurones in the locus coeruleus.
Maubach KA; Martin K; Chicchi G; Harrison T; Wheeldon A; Swain CJ; Cumberbatch MJ; Rupniak NM; Seabrook GR
Neuroscience; 2002; 109(3):609-17. PubMed ID: 11823070
[TBL] [Abstract][Full Text] [Related]
29. Cellular and behavioural profile of the novel, selective neurokinin1 receptor antagonist, vestipitant: a comparison to other agents.
Brocco M; Dekeyne A; Mannoury la Cour C; Touzard M; Girardon S; Veiga S; de Nanteuil G; deJong TR; Olivier B; Millan MJ
Eur Neuropsychopharmacol; 2008 Oct; 18(10):729-50. PubMed ID: 18657401
[TBL] [Abstract][Full Text] [Related]
30. The NK1 receptor antagonist aprepitant attenuates NK1 agonist-induced scratching behaviour in the gerbil after intra-dermal, topical or oral administration.
Costantini VJ; Corsi M; Dünstl G; Bettelini L; Zonzini L; Gerrard P
Exp Dermatol; 2015 Apr; 24(4):312-4. PubMed ID: 25650546
[TBL] [Abstract][Full Text] [Related]
31. Substance P receptor antagonists in psychiatry: rationale for development and therapeutic potential.
Herpfer I; Lieb K
CNS Drugs; 2005; 19(4):275-93. PubMed ID: 15813642
[TBL] [Abstract][Full Text] [Related]
32. Pharmacological depletion of serotonin in the basolateral amygdala complex reduces anxiety and disrupts fear conditioning.
Johnson PL; Molosh A; Fitz SD; Arendt D; Deehan GA; Federici LM; Bernabe C; Engleman EA; Rodd ZA; Lowry CA; Shekhar A
Pharmacol Biochem Behav; 2015 Nov; 138():174-9. PubMed ID: 26476009
[TBL] [Abstract][Full Text] [Related]
33. 5-HT1A receptor agonist affects fear conditioning through stimulations of the postsynaptic 5-HT1A receptors in the hippocampus and amygdala.
Li X; Inoue T; Abekawa T; Weng S; Nakagawa S; Izumi T; Koyama T
Eur J Pharmacol; 2006 Feb; 532(1-2):74-80. PubMed ID: 16460727
[TBL] [Abstract][Full Text] [Related]
34. Selective blockade of NK2 or NK3 receptors produces anxiolytic- and antidepressant-like effects in gerbils.
Salomé N; Stemmelin J; Cohen C; Griebel G
Pharmacol Biochem Behav; 2006 Apr; 83(4):533-9. PubMed ID: 16624395
[TBL] [Abstract][Full Text] [Related]
35. The neurokinin-1 receptor antagonist WIN51,708 attenuates the anxiolytic-like effects of ventralpallidal substance P injection.
Nikolaus S; Huston JP; Hasenöhrl RU
Neuroreport; 1999 Aug; 10(11):2293-6. PubMed ID: 10439451
[TBL] [Abstract][Full Text] [Related]
36. Modulation of anxiety in rats evaluated in the elevated T-maze: evidence of the relationship between substance P and diazepam.
Duzzioni M; Calixto AV; Duarte FS; De Lima TC
Behav Brain Res; 2008 Feb; 187(1):140-5. PubMed ID: 17963853
[TBL] [Abstract][Full Text] [Related]
37. The anxiolytic-like effect of nicotine undergoes rapid tolerance in a model of contextual fear conditioning in rats.
Szyndler J; Sienkiewicz-Jarosz H; Maciejak P; Siemiatkowski M; Rokicki D; Członkowska AI; Płaznik A
Pharmacol Biochem Behav; 2001; 69(3-4):511-8. PubMed ID: 11509211
[TBL] [Abstract][Full Text] [Related]
38. Leptin: a potential anxiolytic by facilitation of fear extinction.
Wang W; Liu SL; Li K; Chen Y; Jiang B; Li YK; Xiao JL; Yang S; Chen T; Chen JG; Li JG; Wang F
CNS Neurosci Ther; 2015 May; 21(5):425-34. PubMed ID: 25645604
[TBL] [Abstract][Full Text] [Related]
39. Effects of cannabidiol and diazepam on behavioral and cardiovascular responses induced by contextual conditioned fear in rats.
Resstel LB; Joca SR; Moreira FA; Corrêa FM; Guimarães FS
Behav Brain Res; 2006 Sep; 172(2):294-8. PubMed ID: 16780966
[TBL] [Abstract][Full Text] [Related]
40. Neurokinin3-R agonism in aged rats has anxiolytic-, antidepressant-, and promnestic-like effects and stimulates ACh release in frontal cortex, amygdala and hippocampus.
Schäble S; Topic B; Buddenberg T; Petri D; Huston JP; de Souza Silva MA
Eur Neuropsychopharmacol; 2011 Jun; 21(6):484-94. PubMed ID: 21342754
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
